前立腺がんの疫学的予測（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Related Report 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.3 Global Trends 12
3.3.1 US 13
3.3.2 5EU 14
3.3.3 Japan, Brazil, and Canada 14
3.4 Forecast Methodology 15
3.4.1 Sources Used 16
3.4.2 Sources Not Used 22
3.4.3 Forecast Assumptions and Methods 23
3.5 Epidemiological Forecast for Prostate Cancer (2013-2023) 26
3.5.1 Diagnosed Incident Cases of Prostate Cancer 26
3.5.2 Age-Specific Diagnosed Incident Cases of Prostate Cancer 28
3.5.3 Age-Standardized Diagnosed Incidence of Prostate Cancer 30
3.5.4 Clinical Stage at Diagnosis 32
3.5.5 Diagnosed Five-Year Prevalent Cases of Prostate Cancer 33
3.5.6 Diagnosed Five-Year Prevalent Cases of CRPC 34
3.5.7 Diagnosed Five-Year Prevalent Cases of Bone Metastases Among CRPC Patients 36
3.6 Discussion 38
3.6.1 Epidemiological Forecast Insight 38
3.6.2 Limitations of the Analysis 39
3.6.3 Strengths of the Analysis 40
4 Appendix 41
4.1 Bibliography 41
4.2 About the Authors 46
4.2.1 Epidemiologists 46
4.2.2 Reviewers 46
4.2.3 Global Director of Therapy Analysis and Epidemiology 47
4.2.4 Global Head of Healthcare 48
4.3 About GlobalData 49
4.4 About EpiCast 49
4.5 Disclaimer 50